Comparison of Oral Zinc Sulfate with Systemic Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis

Table 1

General characteristics of CL studied patients between two treatment groups (MA and ZS).

Drug	Patients	Age, year (mean ± SD)	Males	Females	No. of lesions	Duration of lesions (month)
MA	74	25 ± 19	39	35	127	4 ± 1.5
ZS	26	32 ± 23	11	15	43	4.5 ± 1.5